Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
31 /100
MEDIUM RISK
Score updated Oct 13, 2026

LSBCF — LakeShore Biopharma Co., Ltd Dilution Risk Tracker

Track LSBCF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LSBCF — Get alerts when the score changes →

As of October 13, 2026, LakeShore Biopharma Co., Ltd (LSBCF) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. LakeShore Biopharma Co., Ltd has a market capitalization of $4.12M, 20.77M shares outstanding, 1 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
37
💰 Cash Runway
0
📊 Float Risk
62
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.05 below $1 exchange minimum
🔔 Track LSBCF — Get forecast alerts →

Market Data

Market Cap$4.12M
Shares Outstanding20.77M
Float5.06M
Cash$53.90M
Debt$31.47M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore31/100DilutionWatch score record
Shares Outstanding20.77MVerified float table or market cache
Public Float5.06MVerified float table or market cache
Market Cap$4.12MMarket data cache
Cash Runway38.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 200.0% shares (2026Q1 vs prior)
1 institutional holders · 74.3K shares
#1 BARCLAYS PLC 74.3K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2025-07-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LSBCF Dilution Snapshot

LakeShore Biopharma Co., Ltd (LSBCF) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LSBCF's DilutionScore is currently 31/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 33/100 (Medium risk).

Period Score Risk Level Duration
Oct 12 – Oct 13, 202631/100MEDIUM2 days
Jul 16 – Oct 11, 202633/100MEDIUM87 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track LSBCF Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LSBCF files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LSBCF — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations